Skip to main content
SpringerLink
Log in

Current Treatment of Atopic Dermatitis

  • Chapter
Tacrolimus Ointment

  • 142 Accesses

Abstract

Atopic dermatitis (AD) is an itching skin disease with a relapsing course. It is a clinical manifestation of the atopic syndrome, which is also known as atopy. The genetics of atopy are complex, as it is a multigenic disorder. Patients with atopy may have atopic dermatitis (eczema), allergic (extrinsic) asthma, allergic rhinitis (“hay fever”), allergic conjunctivitis, and gastrointestinal allergy in any sequential order or combination. In fact, a person may have atopy but none of these clinical manifestations. Associated skin disorders include asteatosis (dry skin) and dyshidrotic eczema, easy development of irritant contact dermatitis, as well as a variety of other symptoms and signs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arkwright PD, David TJ (2001) Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J Allergy Clin Immunol 107: 531–534

    Article  PubMed  CAS  Google Scholar 

  2. Atherton DJ (1988) Diet and atopic eczema. Clin Allergy 18: 215–228

    Article  PubMed  CAS  Google Scholar 

  3. Bos JD (2002) Atopiform dermatitis. Br J Dermatol 147: 415–417

    Article  Google Scholar 

  4. Bos JD, Kapsenberg ML, Sillevis Smitt JH (1994) Pathogenesis of atopic eczema. Lancet 343: 1338–1341

    Article  PubMed  CAS  Google Scholar 

  5. Bos JD, Van Leent EJM, Sillevis Smitt JH (1998) The millennium criteria for the diagnosis of atopic dermatitis. Exp Dermatol 7: 132–138

    Article  PubMed  CAS  Google Scholar 

  6. Finlay AY (2001) Quality of life in atopic dermatitis. J Am Acad Dermatol 45: 64–66

    Article  Google Scholar 

  7. Forrest S, Dunn K, Elliott K, Fitzpatrick E, Fullerton J, McCarthy M, Brown J, Hill D, Williamson R (1999) Identifying genes predisposing to atopic eczema. J Allergy Clin Immunol 104: 1066–1070

    Article  PubMed  CAS  Google Scholar 

  8. Goerz G, Lehmann P (1991) Topical treatment with corticosteroids. In: Ruzicka T, Ring J, Przybilla B (eds) Hand-book of atopic eczema. Springer, Berlin Heidelberg New York Tokyo, pp 375–390

    Chapter  Google Scholar 

  9. Hanifin JM, Rajka G (1980) Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 92 (Suppl): 44–47

    Google Scholar 

  10. Holt PG (2000) Parasites, atopy, and the hygiene hypothesis: resolution of a paradox? Lancet 356: 1699–1701

    Article  PubMed  CAS  Google Scholar 

  11. Japanese Dermatological Association (1997) Criteria for the diagnosis of atopic dermatitis. J Dermatol 24: 561

    Google Scholar 

  12. Kalinski P, Hilkens CMU, Wierenga EA, Kapsenberg ML (1999) T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today 20: 561–567

    Article  PubMed  CAS  Google Scholar 

  13. Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E (2001) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357: 1076–1079

    Article  PubMed  Google Scholar 

  14. Kapsenberg ML, Wierenga EA, Bos JD, Jansen HM (1991) Functional subsets of allergen-reactive human CD4+ T-cells. Immunol Today 12: 392–395

    Article  PubMed  CAS  Google Scholar 

  15. Kay J, Gawkrodger DJ, Mortimer MJ, Jaron AG (1994) The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol 30: 35–39

    Article  PubMed  CAS  Google Scholar 

  16. Kristal L, Klein PA (2000) Atopic dermatitis in infants and children. An update. Pediatr Clin North Am 47: 877–895

    Article  CAS  Google Scholar 

  17. Krutmann J, Czech W, Diepgen T, Niedner R, Kapp A, Schöpf E (1992) High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 26: 225–230

    Article  PubMed  CAS  Google Scholar 

  18. Lapidus CS (2001) Role of social factors in atopic dermatitis: the US perspective. J Am Acad Dermatol 45: 41–43

    Article  Google Scholar 

  19. Lever R, MacDonald C, Waugh P, Aitchison T (1998) Randomised controlled trial of advice on an egg exclusion diet in young children with atopic eczema and sensitivity to eggs. Pediatr Allergy Immunol 9: 13–19

    Article  PubMed  CAS  Google Scholar 

  20. Nakagawa H, Ethoh T, Ishibashi Y, Higaki Y, Kawashima M, Torii H, Harada S (1994) Tacrolimus ointment for atopic dermatitis. Lancet 344: 883

    Article  PubMed  CAS  Google Scholar 

  21. Ruzicka Th, Bieber Th, Schöpf E et al. (1997) A short-term trial of tacrolimus ointment for atopic dermatitis. N Engl J Med 337: 816–821

    Article  PubMed  CAS  Google Scholar 

  22. Tan BB, Weald D, Strickland I, Friedmann PS (1996) Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet 347: 15–18

    Article  PubMed  CAS  Google Scholar 

  23. Van Leent EJM, Bos JD (2003) Atopic Dermatitis. In: Katsambas AD, Lotti TM (eds) European Handbook of Dermatological Treatments. 2nd ed. Springer, Berlin Heidelberg New York Tokyo, in press

    Google Scholar 

  24. Van Leent EJM, Gräber M, Thurston M, Wagenaar A, Spuls PhI, Bos JD (1998) Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis. Arch Dermatol 134: 805–809

    Article  PubMed  Google Scholar 

  25. Williams HC (1992) Is the prevalence of atopic dermatitis increasing? Clin Exp Dermatol 17: 385–391

    Article  PubMed  CAS  Google Scholar 

  26. Williams HC, Burney PGJ, Hay RJ et al. (1994) The U.K. Working Party’s Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 131: 383–396

    CAS  Google Scholar 

  27. Williams H, Robertson C, Stewart A et al. (1999) Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 103: 125–138

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. J. D. Bos
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitätsklinikum Düsseldorf Hautklinik, Heinrich-Heine-Universität, Moorenstraße 5, 40225, Düsseldorf, Germany

    Thomas Ruzicka

  2. Hospital for Skin and Allergic Diseases, Department of Dermatology, Helsinki University Central Hospital, Meilahdentie 2, 00250, Helsinki, Finland

    Sakari Reitamo

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Bos, J.D. (2004). Current Treatment of Atopic Dermatitis. In: Ruzicka, T., Reitamo, S. (eds) Tacrolimus Ointment. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10209-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10209-1_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-10211-4

  • Online ISBN: 978-3-662-10209-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation